查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1411496

近距离放射治疗市场：按适应症、产品、给药类型、最终用户划分 - 2024-2030 年全球预测

Brachytherapy Market by Indication (Breast Cancer, Gynecological Cancer, Prostate Cancer), Offering (Devices, Services), Dosage Type, End User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年近距离放射治疗市场规模为9.6201亿美元，2024年将达到10.1287亿美元，2030年将达到14.2357亿美元，复合年增长率为5.75%。

全球近距离放射治疗市场

主要市场统计
基准年[2023] 96201万美元
预测年份 [2024] 1,012,870,000 美元
预测年份 [2030] 1,423.57 百万美元
复合年增长率（%） 5.75%
近距离放射治疗市场-IMG1

FPNV定位矩阵

FPNV定位矩阵对于评估近距离放射治疗市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出资讯的决策。根据评估，供应商被分为四个成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对近距离放射治疗市场供应商的现状进行深入而详细的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析还提供了对该行业竞争特征的宝贵考察，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更资讯的决策并制定有效的策略，从而在市场上获得竞争优势。

该报告对以下几个方面提供了宝贵的见解：

1-市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2-市场开拓：我们深入研究利润丰厚的新兴市场，并分析它们在成熟细分市场中的渗透率。

3- 市场多元化：提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4-竞争力评估与资讯：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况、製造能力等进行全面评估。

5- 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告解决了以下关键问题：

1-近距离放射治疗市场的市场规模与预测是多少？

2-近距离放射治疗市场预测期间需要考虑投资的产品、细分市场、应用和领域有哪些？

3-近距离治疗市场的技术趋势和法律规范是什么？

4-近距离放射治疗市场主要供应商的市场占有率为何？

5-进入近距离治疗市场的适当型态和策略性手段是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 全球癌症盛行率不断上升，需要有效的治疗
      • 疾病的早​​期诊断和治疗趋势
      • 对微创医疗程序的偏好日益增加
    • 抑制因素
      • 近距离放射治疗高成本且复杂
    • 机会
      • 使用个人化医疗进行精准治疗
      • 持续研究和开发以提高近距离放射治疗的有效性
    • 任务
      • 严格的法律规范和缺乏熟练的专业人员
  • 市场区隔分析
  • 市场趋势分析
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法律规范

第六章近距离放射治疗市场（依适应症）

  • 乳癌
  • 妇科癌症
  • 摄护腺癌

第七章近距离放射治疗市场：透过提供

  • 装置
    • 后荷机
    • 施用器
    • 种子
  • 服务

第八章按给药类型分類的近距离放射治疗市场

  • 高剂量率 (HDR) 近距离放射治疗
  • 低剂量率 (LDR) 近距离放射治疗

第 9 章近距离放射治疗市场：依最终用户分类

  • 医院
  • 专科诊所

第10章美洲近距离放射治疗市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太地区近距离放射治疗市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲近距离放射治疗市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争形势

  • FPNV定位矩阵
  • 市场占有率分析：主要企业
  • 主要企业竞争情境分析

第14章竞争产品组合

  • 主要公司简介
    • Accuray Incorporated
    • BEBIG Medical GmbH
    • Becton, Dickinson and Company
    • Best Medical International, Inc.
    • BWX Technologies. Inc.
    • CivaTech Oncology Inc.
    • CIVCO Medical Solutions
    • Eckert & Ziegler Radiopharma GmbH
    • Elekta AB
    • GammaTile
    • Healvita Group GmbH
    • Hologic, Inc.
    • iCAD, Inc.
    • IsoAid, LLC
    • Isoray Medical, Inc. by Perspective Therapeutics
    • Mick Radio-Nuclear Instruments, Inc.
    • Mirion Technologies, Inc.
    • Nihon Medi-Physics Co., Ltd.
    • Qfix
    • Theragenics
    • Varian Medical Systems, Inc.
  • 主要产品系列

第十五章附录

  • 讨论指南
  • 关于许可证和定价
Product Code: MRR-521BAA36EB68

[184 Pages Report] The Brachytherapy Market size was estimated at USD 962.01 million in 2023 and expected to reach USD 1,012.87 million in 2024, at a CAGR 5.75% to reach USD 1,423.57 million by 2030.

Global Brachytherapy Market

KEY MARKET STATISTICS
Base Year [2023] USD 962.01 million
Estimated Year [2024] USD 1,012.87 million
Forecast Year [2030] USD 1,423.57 million
CAGR (%) 5.75%
Brachytherapy Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Brachytherapy Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Brachytherapy Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Brachytherapy Market, highlighting leading vendors and their innovative profiles. These include Accuray Incorporated, BEBIG Medical GmbH, Becton, Dickinson and Company, Best Medical International, Inc., BWX Technologies. Inc., CivaTech Oncology Inc., CIVCO Medical Solutions, Eckert & Ziegler Radiopharma GmbH, Elekta AB, GammaTile, Healvita Group GmbH, Hologic, Inc., iCAD, Inc., IsoAid, LLC, Isoray Medical, Inc. by Perspective Therapeutics, Mick Radio-Nuclear Instruments, Inc., Mirion Technologies, Inc., Nihon Medi-Physics Co., Ltd., Qfix, Theragenics, and Varian Medical Systems, Inc..

Market Segmentation & Coverage

This research report categorizes the Brachytherapy Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Indication
    • Breast Cancer
    • Gynecological Cancer
    • Prostate Cancer
  • Offering
    • Devices
      • Afterloaders
      • Applicators
      • Seeds
    • Services
  • Dosage Type
    • High-Dose Rate (HDR) Brachytherapy
    • Low-Dose Rate (LDR) Brachytherapy
  • End User
    • Hospitals
    • Specialty Clinic
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Brachytherapy Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Brachytherapy Market?

3. What are the technology trends and regulatory frameworks in the Brachytherapy Market?

4. What is the market share of the leading vendors in the Brachytherapy Market?

5. Which modes and strategic moves are suitable for entering the Brachytherapy Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Brachytherapy Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of cancer worldwide and need for efficient treatment
      • 5.1.1.2. Inclination toward early diagnosis and treatment of diseases
      • 5.1.1.3. Increasing preference for minimally invasive medical procedures
    • 5.1.2. Restraints
      • 5.1.2.1. High cost and complexity in brachytherapy
    • 5.1.3. Opportunities
      • 5.1.3.1. Utilization of personalized medicine approach to deliver precise treatment
      • 5.1.3.2. Ongoing R&D to enhance the efficacy of brachytherapy
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulatory framework and dearth of skilled professionals
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Brachytherapy Market, by Indication

  • 6.1. Introduction
  • 6.2. Breast Cancer
  • 6.3. Gynecological Cancer
  • 6.4. Prostate Cancer

7. Brachytherapy Market, by Offering

  • 7.1. Introduction
  • 7.2. Devices
    • 7.3.1. Afterloaders
    • 7.3.2. Applicators
    • 7.3.3. Seeds
  • 7.3. Services

8. Brachytherapy Market, by Dosage Type

  • 8.1. Introduction
  • 8.2. High-Dose Rate (HDR) Brachytherapy
  • 8.3. Low-Dose Rate (LDR) Brachytherapy

9. Brachytherapy Market, by End User

  • 9.1. Introduction
  • 9.2. Hospitals
  • 9.3. Specialty Clinic

10. Americas Brachytherapy Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Brachytherapy Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Brachytherapy Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
  • 13.2. Market Share Analysis, By Key Player
  • 13.3. Competitive Scenario Analysis, By Key Player

14. Competitive Portfolio

  • 14.1. Key Company Profiles
    • 14.1.1. Accuray Incorporated
    • 14.1.2. BEBIG Medical GmbH
    • 14.1.3. Becton, Dickinson and Company
    • 14.1.4. Best Medical International, Inc.
    • 14.1.5. BWX Technologies. Inc.
    • 14.1.6. CivaTech Oncology Inc.
    • 14.1.7. CIVCO Medical Solutions
    • 14.1.8. Eckert & Ziegler Radiopharma GmbH
    • 14.1.9. Elekta AB
    • 14.1.10. GammaTile
    • 14.1.11. Healvita Group GmbH
    • 14.1.12. Hologic, Inc.
    • 14.1.13. iCAD, Inc.
    • 14.1.14. IsoAid, LLC
    • 14.1.15. Isoray Medical, Inc. by Perspective Therapeutics
    • 14.1.16. Mick Radio-Nuclear Instruments, Inc.
    • 14.1.17. Mirion Technologies, Inc.
    • 14.1.18. Nihon Medi-Physics Co., Ltd.
    • 14.1.19. Qfix
    • 14.1.20. Theragenics
    • 14.1.21. Varian Medical Systems, Inc.
  • 14.2. Key Product Portfolio

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. BRACHYTHERAPY MARKET RESEARCH PROCESS
  • FIGURE 2. BRACHYTHERAPY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. BRACHYTHERAPY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. BRACHYTHERAPY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. BRACHYTHERAPY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. BRACHYTHERAPY MARKET DYNAMICS
  • FIGURE 7. BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 8. BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2023 VS 2030 (%)
  • FIGURE 10. BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2023 VS 2030 (%)
  • FIGURE 12. BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. BRACHYTHERAPY MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 14. BRACHYTHERAPY MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS BRACHYTHERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS BRACHYTHERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES BRACHYTHERAPY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES BRACHYTHERAPY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC BRACHYTHERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC BRACHYTHERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BRACHYTHERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA BRACHYTHERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. BRACHYTHERAPY MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 24. BRACHYTHERAPY MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. BRACHYTHERAPY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. BRACHYTHERAPY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BRACHYTHERAPY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 6. BRACHYTHERAPY MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. BRACHYTHERAPY MARKET SIZE, BY GYNECOLOGICAL CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. BRACHYTHERAPY MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 10. BRACHYTHERAPY MARKET SIZE, BY DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 12. BRACHYTHERAPY MARKET SIZE, BY AFTERLOADERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. BRACHYTHERAPY MARKET SIZE, BY APPLICATORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. BRACHYTHERAPY MARKET SIZE, BY SEEDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. BRACHYTHERAPY MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 17. BRACHYTHERAPY MARKET SIZE, BY HIGH-DOSE RATE (HDR) BRACHYTHERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. BRACHYTHERAPY MARKET SIZE, BY LOW-DOSE RATE (LDR) BRACHYTHERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 20. BRACHYTHERAPY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. BRACHYTHERAPY MARKET SIZE, BY SPECIALTY CLINIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS BRACHYTHERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES BRACHYTHERAPY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC BRACHYTHERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 60. AUSTRALIA BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 61. AUSTRALIA BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 62. AUSTRALIA BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 63. AUSTRALIA BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 65. CHINA BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 66. CHINA BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 67. CHINA BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 68. CHINA BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 70. INDIA BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 71. INDIA BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 72. INDIA BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 73. INDIA BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. INDIA BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 75. INDONESIA BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 76. INDONESIA BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 77. INDONESIA BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 78. INDONESIA BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. INDONESIA BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 80. JAPAN BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 81. JAPAN BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 82. JAPAN BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 83. JAPAN BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. JAPAN BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 85. MALAYSIA BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 86. MALAYSIA BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 87. MALAYSIA BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 88. MALAYSIA BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. MALAYSIA BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 90. PHILIPPINES BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 91. PHILIPPINES BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 92. PHILIPPINES BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 93. PHILIPPINES BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. PHILIPPINES BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 95. SINGAPORE BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 96. SINGAPORE BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 97. SINGAPORE BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 98. SINGAPORE BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. SINGAPORE BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 100. SOUTH KOREA BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 101. SOUTH KOREA BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 102. SOUTH KOREA BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 103. SOUTH KOREA BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. SOUTH KOREA BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 105. TAIWAN BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 106. TAIWAN BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 107. TAIWAN BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 108. TAIWAN BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. TAIWAN BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 110. THAILAND BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 111. THAILAND BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 112. THAILAND BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 113. THAILAND BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. THAILAND BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 115. VIETNAM BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 116. VIETNAM BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 117. VIETNAM BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 118. VIETNAM BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. VIETNAM BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 120. EUROPE, MIDDLE EAST & AFRICA BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 121. EUROPE, MIDDLE EAST & AFRICA BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA BRACHYTHERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 126. DENMARK BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 127. DENMARK BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 128. DENMARK BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 129. DENMARK BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. DENMARK BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 131. EGYPT BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 132. EGYPT BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 133. EGYPT BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 134. EGYPT BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. EGYPT BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 136. FINLAND BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 137. FINLAND BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 138. FINLAND BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 139. FINLAND BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. FINLAND BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 141. FRANCE BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 142. FRANCE BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 143. FRANCE BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 144. FRANCE BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. FRANCE BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 146. GERMANY BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 147. GERMANY BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 148. GERMANY BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 149. GERMANY BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. GERMANY BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 151. ISRAEL BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 152. ISRAEL BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 153. ISRAEL BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 154. ISRAEL BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. ISRAEL BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 156. ITALY BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 157. ITALY BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 158. ITALY BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 159. ITALY BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. ITALY BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 161. NETHERLANDS BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 162. NETHERLANDS BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 163. NETHERLANDS BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 164. NETHERLANDS BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. NETHERLANDS BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 166. NIGERIA BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 167. NIGERIA BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 168. NIGERIA BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 169. NIGERIA BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. NIGERIA BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 171. NORWAY BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 172. NORWAY BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 173. NORWAY BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 174. NORWAY BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. NORWAY BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 176. POLAND BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 177. POLAND BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 178. POLAND BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 179. POLAND BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. POLAND BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 181. QATAR BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 182. QATAR BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 183. QATAR BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 184. QATAR BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. QATAR BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 186. RUSSIA BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 187. RUSSIA BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 188. RUSSIA BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 189. RUSSIA BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. RUSSIA BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 191. SAUDI ARABIA BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 192. SAUDI ARABIA BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 193. SAUDI ARABIA BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 194. SAUDI ARABIA BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 195. SAUDI ARABIA BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 196. SOUTH AFRICA BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 197. SOUTH AFRICA BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 198. SOUTH AFRICA BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 199. SOUTH AFRICA BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 200. SOUTH AFRICA BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 201. SPAIN BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 202. SPAIN BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 203. SPAIN BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 204. SPAIN BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 205. SPAIN BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 206. SWEDEN BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 207. SWEDEN BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 208. SWEDEN BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 209. SWEDEN BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 210. SWEDEN BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 211. SWITZERLAND BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 212. SWITZERLAND BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 213. SWITZERLAND BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 214. SWITZERLAND BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 215. SWITZERLAND BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 216. TURKEY BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 217. TURKEY BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 218. TURKEY BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 219. TURKEY BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 220. TURKEY BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 221. UNITED ARAB EMIRATES BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 222. UNITED ARAB EMIRATES BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 223. UNITED ARAB EMIRATES BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 224. UNITED ARAB EMIRATES BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 225. UNITED ARAB EMIRATES BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED KINGDOM BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED KINGDOM BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED KINGDOM BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED KINGDOM BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED KINGDOM BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 231. BRACHYTHERAPY MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 232. BRACHYTHERAPY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 233. BRACHYTHERAPY MARKET LICENSE & PRICING